1-6 of 6
Jonathan W. Friedberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma

Radhakrishnan Ramchandren, Ranjana H. Advani, Stephen M. Ansell, Nancy L. Bartlett, Robert Chen, Joseph M. Connors, Tatyana Feldman, Andres Forero-Torres, Jonathan W. Friedberg, Ajay K. Gopal, Leo I. Gordon, John Kuruvilla, Kerry J. Savage, Anas Younes, Gerald Engley, Thomas J. Manley, Keenan Fenton, David J. Straus
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (6): 1718–1726.
https://doi.org/10.1158/1078-0432.CCR-18-2435
Published: 15 March 2019
View article titled, Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma
Open the PDF for Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma in another window
Includes: Supplementary data
Journal Articles

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Kevin R. Kelly, Jonathan W. Friedberg, Steven I. Park, Kevin McDonagh, John Hayslip, Daniel Persky, Jia Ruan, Soham Puvvada, Peter Rosen, Swaminathan Padmanabhan Iyer, Alexandra Stefanovic, Steven H. Bernstein, Steven Weitman, Anand Karnad, Gregory Monohan, Ari VanderWalde, Raul Mena, Monika Schmelz, Catherine Spier, Susan Groshen, Karthik Venkatakrishnan, Xiaofei Zhou, Emily Sheldon-Waniga, E. Jane Leonard, Daruka Mahadevan
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (24): 6150–6159.
https://doi.org/10.1158/1078-0432.CCR-18-0286
Published: 13 December 2018
View article titled, Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma
Open the PDF for Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + 131Iodine—Tositumomab

Oliver W. Press, Joseph M. Unger, Lisa M. Rimsza, Jonathan W. Friedberg, Michael LeBlanc, Myron S. Czuczman, Mark Kaminski, Rita M. Braziel, Catherine Spier, Ajay K. Gopal, David G. Maloney, Bruce D. Cheson, Shaker R. Dakhil, Thomas P. Miller, Richard I. Fisher
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (23): 6624–6632.
https://doi.org/10.1158/1078-0432.CCR-13-1120
Published: 01 December 2013
View article titled, A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + <sup>131</sup>Iodine—Tositumomab
Open the PDF for A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP–Rituximab versus CHOP + <sup>131</sup>Iodine—Tositumomab in another window
Includes: Supplementary data
Journal Articles

New Strategies in Diffuse Large B-cell Lymphoma: Translating Findings from Gene Expression Analyses into Clinical Practice

Jonathan W. Friedberg
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (19): 6112–6117.
https://doi.org/10.1158/1078-0432.CCR-11-1073
Published: 02 October 2011
View article titled, New Strategies in Diffuse Large B-cell Lymphoma: Translating Findings from Gene Expression Analyses into Clinical Practice
Open the PDF for New Strategies in Diffuse Large B-cell Lymphoma: Translating Findings from Gene Expression Analyses into Clinical Practice in another window
Journal Articles

Radioimmunotherapy for Non-Hodgkin’s Lymphoma

Jonathan W. Friedberg
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (23): 7789–7791.
https://doi.org/10.1158/1078-0432.CCR-04-1706
Published: 07 December 2004
View article titled, Radioimmunotherapy for Non-Hodgkin’s Lymphoma
Open the PDF for Radioimmunotherapy for Non-Hodgkin’s Lymphoma in another window
Journal Articles

Developing New Monoclonal Antibodies for Aggressive Lymphoma: A Challenging Road in the Rituximab Era

Jonathan W. Friedberg
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (16): 5297–5298.
https://doi.org/10.1158/1078-0432.CCR-04-0922
Published: 24 August 2004
View article titled, Developing New Monoclonal Antibodies for Aggressive Lymphoma: <subtitle>A Challenging Road in the Rituximab Era</subtitle>
Open the PDF for Developing New Monoclonal Antibodies for Aggressive Lymphoma: <subtitle>A Challenging Road in the Rituximab Era</subtitle> in another window